Abstract Details

Title A Plasma-based Biomarker Panel Identifies Preclinical Alzheimer's Disease

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 001

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark Mapstone, PhD (University of California, Irvine) PRESENTER	Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brain Neurotherapy Bio, Inc. Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon, Inc. Dr. Mapstone has received intellectual property interests from a discovery or technology relating to health care.
Massimo Fiandaca	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Claudia Kawas, MD (University of California, Irvine)	The institution of Dr. Kawas has received research support from NIH.
Howard J. Federoff, MD, PhD (University of California, Irvine)	No disclosure on file